Complications and continuation of intrauterine device use among commercially insured teenagers

Obstetrics and Gynecology

Volumn 121, Issue 5, 2013, Pages 951-958

  Berenson, Abbey B ^a   Tan, Alai ^a   Hirth, Jacqueline M ^a   Wilkinson, Gregg S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER INTRAUTERINE DEVICE; LEVONORGESTREL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AMENORRHEA; ARTICLE; BLEEDING; DEVICE RECALL; DRUG DELIVERY SYSTEM; DYSMENORRHEA; DYSPAREUNIA; ECTOPIC PREGNANCY; FEMALE; HEALTH INSURANCE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MEDICAL DEVICE COMPLICATION; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; METRORRHAGIA; OUTCOME ASSESSMENT; PELVIC INFLAMMATORY DISEASE; PREGNANCY DISORDER; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PROSTHESIS FAILURE; SPONTANEOUS ABORTION; UTERINE CERVICITIS; UTERUS BLEEDING; UTERUS DISEASE; UTERUS PERFORATION;

ADOLESCENT; ADULT; AGE FACTORS; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; INSURANCE, HEALTH; INTRAUTERINE DEVICES; INTRAUTERINE DEVICES, COPPER; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84879086246     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31828b63a0     Document Type: Article

References (25)

1. Sivin I, Stern J, Coutinho E, Mattos CER, Mahgoub SE, Diaz S, et al. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS. Contraception 1991; 44: 473-80.
2. Foster DG, Rostovtseva DP, Brindis CD, Biggs A, Hulett D, Darney PD. Cost savings from the provision of specific methods of contraception in a publicly funded program. Am J Public Health 2009; 99: 446-51.
3. Trussell J, Lalla AM, Daon QV, Reyes E, Pinto L, Gricar J. Cost effectiveness of contraceptives in the United States. Contraception 2009; 79: 5-14.
4. World Health Organization. Medical eligibility criteria for contraceptive use. 3rd ed. Geneva (Switzerland): WHO; 2004.
5. Intrauterine device and adolescents. ACOG Committee Opinion No. 392. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007; 110: 1493-5.
6. Understanding and using the U.S. Medical Eligibility Criteria For Contraceptive Use, 2010. Committee Opinion No. 505. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011; 118: 754-60.
7. Xu X, Macaluso M, Ouyang L, Kulczycki A, Grosse S. Revival of the IUD: Increased use among US women with employer-sponsored insurance, 2002-2007. Available at: http://www.academyhealth.org/files/2010/saturday/xu.pdf. Retrieved December 13, 2012.
8. Harper CC, Blum M, Thiel de Bocanegra T, Darney PD, Speidel JJ, Policar M, et al. Challenges in translating evidence to practice: the provision of intrauterine contraception. Obstet Gynecol 2008; 111: 1359-69.
9. Madden T, Allsworth JE, Hladky KJ, Secura GM, Peipert JF. Intrauterine contraception in Saint Louis: a survey of obstetrician and gynecologists' knowledge and attitudes. Contraception 2010; 81: 112-6.
10. Kulier R, O'Brien PA, Helmerhorst FM, Usher-Patel M, d'Arcangues C. Copper containing, framed intrauterine devices for contraception. The Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD005347. DOI: 10.1002/14651858.CD005347.pub3.
11. French R, Sorhaindo AM, Huib AM, Mansour DD, Robinson AA, Logan S, et al. Progestogen-releasing intrauterine systems versus other forms of reversible contraceptives for contraception. The Cochrane Database of Systematic Reviews 2010, Issue 2. DOI: 10.1002/14651858.CD001776.pub2.
12. Paterson H, Ashton J, Harrison-Woolrych M. A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents. Contraception 2009; 79: 433-8.
13. Godfrey EM, Memmel LM, Neustadt A, Shah M, Nicosia A, Moorthie M, et al. Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T380A. Contraception 2010; 81: 123-7.
14. Teal SB, Sheeder J. IUD use in adolescent mothers: retention, failure, and reasons for discontinuation. Contraception 2012; 85: 270-4.
15. Lara-Torre E, Spotswood L, Correia N, Weiss PM. Intrauterine contraception in adolescents and young women: a descriptive study of use, side effects, and compliance. J Pediatr Adolesc Gynecol 2011; 24: 39-41.
16. Albright D. Clinformatics data Mart training conducted at the University of Texas Medical Branch; August 21, 2012.
17. Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, et al. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 2011; 365: 1896-904.
18. Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, et al. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 2011; 306: 2673-83.
19. Kruzikas D, Smith JS, Harley C. Costs associated with management of cervical human papillomavirus-related conditions. Cancer Epidemiol Biomarkers Prev 2012; 21: 1469-78.
20. Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ. Use of contraception and use of family planning services in the US: 1982-2002. Adv Data 2004: 1-36.
21. Trussell J, Vaughan B. Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999; 31: 64-72, 93.
22. Hubacher D, Finer LB, Espey E. Renewed interest in intrauterine contraception in the United States: evidence and explanation. Contraception 2011; 83: 291-4.
23. Glasier AF, Smith KB, van der Spuy ZM, Ho PC, Cheng L, Dada K, et al. Amenorrhea associated with contraception - an international study on acceptability. Contraception 2003; 67: 1-8.
24. Grimes DA. Intrauterine device and upper genital tract infection. Lancet 2000; 356: 1013-9.
25. Vaughan B, Trussell J, Kost K, Singh S, Jones R. Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth. Contraception 2008; 78: 271-83.